Strategies to reduce toxicities and improve outcomes in renal transplant recipientsLO, Agnes; ALLOWAY, Rita R.Pharmacotherapy. 2002, Vol 22, Num 3, pp 316-328, issn 0277-0008Article

Renal transplantation in high-risk patientsWEIMERT, Nicole A; ALLOWAY, Rita R.Drugs (Basel). 2007, Vol 67, Num 11, pp 1603-1627, issn 0012-6667, 25 p.Article

YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa studyOSAMA GABER, A; MULGAONKAR, Shamkant; LIPSHUTZ, Gerald et al.Clinical transplantation. 2011, Vol 25, Num 4, pp 523-533, issn 0902-0063, 11 p.Article

Once-daily tacrolimus extended release formulation : Experience at 2 years postconversion from a prograf-based regimen in stable liver transplant recipientsFLORMAN, Sander; ALLOWAY, Rita; DHADDA, Shobha et al.Transplantation. 2007, Vol 83, Num 12, pp 1639-1642, issn 0041-1337, 4 p.Article

Donors with central nervous system malignancies: Are they truly safe? CommentaryBUELL, Joseph F; TROFE, Jennifer; SETHURAMAN, Gopalan et al.Transplantation. 2003, Vol 76, Num 2, pp 280-281, issn 0041-1337, 6 p.Article

Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipientsALLOWAY, Rita; STEINBERG, Steven; WISEMANDLE, Kathleen et al.Transplantation. 2007, Vol 83, Num 12, pp 1648-1651, issn 0041-1337, 4 p.Article

Simultaneous corticosteroid avoidance and calcineurin inhibitor minimization in renal transplantationALEXANDER, J. Wesley; GOODMAN, Hope R; HANAWAY, Michael et al.Transplant international. 2006, Vol 19, Num 4, pp 295-302, issn 0934-0874, 8 p.Article

A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysisSTRATTA, Robert J; ALLOWAY, Rita R; HODGE, Ernest et al.Clinical transplantation. 2002, Vol 16, Num 1, pp 60-68, issn 0902-0063Article

Two-dose daclizumab regimen in simultaneous kidney-pancreas transplant recipients: Primary endpoint analysis of a multicenter, randomized studySTRATTA, Robert J; ALLOWAY, Rita R; LO, Agnes et al.Transplantation. 2003, Vol 75, Num 8, pp 1260-1266, issn 0041-1337, 7 p.Conference Paper

The effect of gut metabolism on tacrolimus bioavailability in renaltransplant recipientsTUTEJA, Sony; ALLOWAY, Rita R; JOHNSON, Julie A et al.Transplantation. 2001, Vol 71, Num 9, pp 1303-1307, issn 0041-1337Article

Monitoring of inosine monophosphate dehydrogenase activity as a biomarker for mycophenolic acid effect : Potential clinical implicationsWEIMERT, Nicole A; DEROTTE, Maurits; ALLOWAY, Rita R et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 141-149, issn 0163-4356, 9 p.Article

Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients : a pilot studyROGERS, Christin C; ALLOWAY, Rita R; ALEXANDER, J. Wesley et al.Clinical transplantation. 2008, Vol 22, Num 3, pp 281-291, issn 0902-0063, 11 p.Article

Risk assessment of immunosuppressive therapy in facial transplantationVASILIC, Dalibor; ALLOWAY, Rita R; BARKER, John H et al.Plastic and reconstructive surgery (1963). 2007, Vol 120, Num 3, pp 657-668, issn 0032-1052, 12 p.Article

Proteasome Inhibition for Antibody-Mediated Allograft RejectionSADAKA, Basma; ALLOWAY, Rita R; SHIELDS, Adele R et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 263-269, issn 0037-1963, 7 p.Article

De Novo Cancers Arising in Organ Transplant Recipients are Associated With Adverse Outcomes Compared With the General PopulationYUN MIAO; EVERLY, Jason J; GROSS, Thomas G et al.Transplantation. 2009, Vol 87, Num 9, pp 1347-1359, issn 0041-1337, 13 p.Article

Prospective Evaluation of the Toxicity Profile of Proteasome Inhibitor―Based Therapy in Renal Transplant Candidates and RecipientsSCHMIDT, Nicole; ALLOWAY, Rita R; WALSH, R. Carlin et al.Transplantation. 2012, Vol 94, Num 4, pp 352-361, issn 0041-1337, 10 p.Article

Experience with 274 cardiac Transplant recipients with posttransplant lymphoproliferative disorder: A report from the israel penn International Transplant Tumor RegistryAULL, Meredith J; BUELL, Joseph F; TROFE, Jennifer et al.Transplantation. 2004, Vol 78, Num 11, pp 1676-1682, issn 0041-1337, 7 p.Article

Initial clinical experience with interleukin-2 receptor antagonist induction in combination with tacrolimus, mycophenolate mofetil and steroids in simultaneous kidney-pancreas transplantationLO, Agnes; STRATTA, Robert J; ALLOWAY, Rita R et al.Transplant international. 2001, Vol 14, Num 6, pp 396-404, issn 0934-0874Article

Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipientsBRUCE, David S; SOLLINGER, Hans W; HUMAR, Abhinav et al.Transplantation. 2001, Vol 72, Num 10, pp 1637-1643, issn 0041-1337Article

Cardiovascular risk, cardiovascular events, and metabolic syndrome in renal transplantation : comparison of early steroid withdrawal and chronic steroidsRIKE, Adele H; MOGILISHETTY, Gautham; ALLOWAY, Rita R et al.Clinical transplantation. 2008, Vol 22, Num 2, pp 229-235, issn 0902-0063, 7 p.Article

Recurrence risk after organ transplantation in patients with a history of Hodgkin disease or non-Hodgkin lymphomaTROFE, Jennifer; BUELL, Joseph F; WOODLE, E. Steve et al.Transplantation. 2004, Vol 78, Num 7, pp 972-977, issn 0041-1337, 6 p.Article

Characteristics and survival patterns of solid organ Transplant patients developing de novo colon and rectal CancerPAPACONSTANTINOU, Harry T; SKLOW, Bradford; HANAWAY, Michael J et al.Diseases of the colon & rectum. 2004, Vol 47, Num 11, pp 1898-1903, issn 0012-3706, 6 p.Article

The effect or CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patientsYATES, Charles R; WENHUI ZHANG; PENGFEI SONG et al.Journal of clinical pharmacology. 2003, Vol 43, Num 6, pp 555-564, issn 0091-2700, 10 p.Article

Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome InhibitionCARLIN WALSH, R; BRAILEY, Paul; MOGILISHETTY, Gautham et al.Transplantation. 2011, Vol 91, Num 11, pp 1218-1226, issn 0041-1337, 9 p.Article

Bortezomib Provides Effective Therapy for Antibody-and Cell-Mediated Acute RejectionEVERLY, Matthew J; EVERLY, Jason J; CARDI, Michael et al.Transplantation. 2008, Vol 86, Num 12, pp 1754-1761, issn 0041-1337, 8 p.Article